Quick consults in hematology: In support of active surveillance versus treatment of high‐risk smoldering multiple myeloma outside of a clinical trial

Abstract

Smoldering multiple myeloma does not represent a disease but is a statistical estimate of the risk of developing symptomatic multiple myeloma over a specified time interval. In aggregate, for all patients